Ibrahim M. Labouta
Alexandria, ALX, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Challenging the Biginelli scaffold to surpass the first line antitubercular drugs: Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibition activity and molecular modelling studies.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: September 11, 2024
New tetrahydropyrimidine-1,2,3-triazole clubbed compounds: Antitubercular activity and Thymidine Monophosphate Kinase (TMPKmt) inhibition.
Journal: Bioorganic chemistry
Published: September 16, 2022
Discovery of a novel DNA binding agent via design and synthesis of new thiazole hybrids and fused 1,2,4-triazines as potential antitumor agents: Computational, spectrometric and in silico studies.
Journal: Bioorganic chemistry
Published: March 13, 2019
Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents.
Journal: Bioorganic chemistry
Published: December 30, 2018
Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
Journal: Bioorganic chemistry
Published: June 11, 2018
Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
Journal: Bioorganic chemistry
Published: April 25, 2018
Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents.
Journal: Bioorganic chemistry
Published: November 19, 2017
Design, synthesis and molecular modeling studies of new series of antitumor 1,2,4-triazines with potential c-Met kinase inhibitory activity.
Journal: Bioorganic chemistry
Published: August 09, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026